Literature DB >> 6417753

Structural correlates of immunoglobulin diversity.

M Potter.   

Abstract

VL and VH domains, from different species and with widely different primary structures, interact with each other in the same way to create the globular FV region. Much of the FV is a highly conserved framework structure that is probably common to most, if not all, mammalian FV regions. The extensive contoured frontal surface of the FV is composed of highly variable polypeptide segments (Wu-Kabat complementarity-determining regions). These segments are derived from parts of VL, VH, JH gene products and most of the D gene product. This surface is currently considered to be the most likely location of the antigen-binding sites. The firm immunochemical data based on identification of contacting amino acids supporting this location are still, however, very fragmentary. VL and VH gene products form a large part of the potential antigen-reactive surface. Hence, combinations of different VL and VH gene products are the largest source of structural diversity. The JL and JH gene products have chiefly structural functions in maintaining domain architecture and controlling some interactions between VL and VH domains. The VL-J junction amino acid can provide unique structural properties in the deeper accesses of the potential antigen reaction surface. The VHD-JH junction is more superficial and could be, but has not yet been, directly implicated in antigen binding. The D gene product and the additional amino acids associated with the (VH-D-JH) rearrangement process do determine a substructural part of the potential antigen reactive surface. The D gene product (a connecting segment between two beta strands) can have many different secondary structures. Functionally, the D region product could interact with VL-CDR-1 amino acids to create a specific contour of the antigen reaction surface. Curiously, primary structural variations in H3 have not yet been directly implicated in antigen binding. Much remains to be learned about the role of VH-D-JH rearrangement in antibody diversity. The major genetic factors in creating structural diversity are the multiple VL and VH gene libraries. The gene rearrangement process provides a further amplification. Somatic mutations are yet another additional mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417753     DOI: 10.1007/BF02918394

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN: 0252-9564


  53 in total

1.  Nuclear RNA precursors in the processing pathway to MOPC 21 kappa light chain messenger RNA.

Authors:  M Gilmore-Hebert; R Wall
Journal:  J Mol Biol       Date:  1979-12-25       Impact factor: 5.469

2.  The arrangement and rearrangement of antibody genes.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

3.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

4.  Antibody diversity.

Authors:  J G Seidman; A Leder; M Nau; B Norman; P Leder
Journal:  Science       Date:  1978-10-06       Impact factor: 47.728

5.  Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions.

Authors:  D J McKean; M Bell; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 6.  beta-Sheet topology and the relatedness of proteins.

Authors:  J S Richardson
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

7.  Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes.

Authors:  S Cory; B M Tyler; J M Adams
Journal:  J Mol Appl Genet       Date:  1981

8.  Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways.

Authors:  P Early; J Rogers; M Davis; K Calame; M Bond; R Wall; L Hood
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

9.  kappa-Chain restriction in anti-galactan antibodies.

Authors:  M Pawlita; M Potter; S Rudikoff
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

10.  Immunoglobulin heavy chains from anti-inulin myeloma proteins: evidence for a new heavy chain joining segment.

Authors:  S Rudikoff; M Potter
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

View more
  5 in total

1.  IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics.

Authors:  Simona Saporiti; Chiara Parravicini; Carlo Pergola; Uliano Guerrini; Mara Rossi; Fabio Centola; Ivano Eberini
Journal:  Biophys J       Date:  2021-10-26       Impact factor: 4.033

2.  The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans.

Authors:  Manoj Kumar Pandey
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

3.  Platform for high-throughput antibody selection using synthetically-designed antibody libraries.

Authors:  Melissa Batonick; Erika G Holland; Valeria Busygina; Dawn Alderman; Brian K Kay; Michael P Weiner; Margaret M Kiss
Journal:  N Biotechnol       Date:  2015-11-24       Impact factor: 5.079

Review 4.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

5.  Global variability of the human IgG glycome.

Authors:  Jerko Štambuk; Natali Nakić; Frano Vučković; Maja Pučić-Baković; Genadij Razdorov; Irena Trbojević-Akmačić; Mislav Novokmet; Toma Keser; Marija Vilaj; Tamara Štambuk; Ivan Gudelj; Mirna Šimurina; Manshu Song; Hao Wang; Marijana Peričić Salihović; Harry Campbell; Igor Rudan; Ivana Kolčić; Leigh Anne Eller; Paul McKeigue; Merlin L Robb; Jonas Halfvarson; Metin Kurtoglu; Vito Annese; Tatjana Škarić-Jurić; Mariam Molokhia; Ozren Polašek; Caroline Hayward; Hannah Kibuuka; Kujtim Thaqi; Dragan Primorac; Christian Gieger; Sorachai Nitayaphan; Tim Spector; Youxin Wang; Therese Tillin; Nish Chaturvedi; James F Wilson; Moses Schanfield; Maxim Filipenko; Wei Wang; Gordan Lauc
Journal:  Aging (Albany NY)       Date:  2020-08-12       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.